Ixekizumab treatment shows a neutral impact on cardiovascular parameters in patients with moderate-to-severe plaque psoriasis: Results from UNCOVER-1, UNCOVER-2, and UNCOVER-3
Alexander Egeberg, Jashin J. Wu, Neil Korman, James A. Solomon, Orin Goldblum, Fangyi Zhao, Lotus Mallbris
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Ixekizumab treatment shows a neutral impact on cardiovascular parameters in patients with moderate-to-severe plaque psoriasis: Results from UNCOVER-1, UNCOVER-2, and UNCOVER-3'. Together they form a unique fingerprint.